Arino S, Bayer A
University Department of Geriatric Medicine, Cardiff Royal Infirmary, UK.
Gerontology. 1993;39(1):33-7. doi: 10.1159/000213512.
A perceived reluctance by many doctors to consider the use of thrombolytic therapy in elderly patients with acute myocardial infarction prompted us to investigate the potential influence of pre-existing medical pathology on use of fibrinolysis. Of 251 patients consecutively admitted to hospital with suspected acute myocardial infarction, absolute contra-indications to thrombolysis were found in 9 (4%) patients and relative contra-indications in a further 82 (31%) patients. This study suggests that the presence of contra-indications plays a small role in influencing the potential use of thrombolysis in the elderly. Age itself should not be assumed to be inevitably associated with an unacceptable rate of contra-indications for thrombolytic therapy.
许多医生明显不愿考虑对老年急性心肌梗死患者使用溶栓疗法,这促使我们研究既往存在的内科疾病对纤维蛋白溶解疗法使用的潜在影响。在连续入院的251例疑似急性心肌梗死患者中,9例(4%)患者存在溶栓的绝对禁忌证,另有82例(31%)患者存在相对禁忌证。本研究提示,禁忌证的存在对影响老年患者溶栓潜在使用方面作用较小。不应想当然地认为年龄本身必然与不可接受的溶栓治疗禁忌证发生率相关。